Narcolepsy Archives - PharmaLive

Jazz Pharmaceuticals completes U.S. divestiture of Sunosi to Axsome Therapeutics

Business, Daytime Sleepiness, Divestments, Narcolepsy, Obstructive Sleep Apnea (OSA), Sleep Disorders, Sleepiness, Therapeutics

Jazz Pharmaceuticals plc completed the divestiture of Sunosi (solriamfetol) in the United States. to Axsome Therapeutics Inc.

May 9, 2022/by PR Newswire

Jazz Pharma’s sleep disorder drug gets European panel backing

Narcolepsy, Obstructive Sleep Apnea (OSA), Sleep Disorders

Jazz Pharmaceuticals Plc’s treatment for a form of sleep disorder was recommended for approval by a panel of the European Medicines Agency (EMA).

November 15, 2019/by Reuters Health

FDA Approves First Non-Controlled Substance Treatment for Narcolepsy

Approvals, Excessive Daytime Sleepiness, FDA, FDA/Regulatory, First-In-Class, Narcolepsy, Narcolepsy, Neuropeptides, Sleep Disorders

Harmony Biosciences snagged approval from the U.S. FDA for the company’s first commercial product, a treatment for narcolepsy.

August 15, 2019/by BioSpace